View Item 

Show simple item record

EP4 and EP2 Receptor Activation of Protein Kinase A by Prostaglandin E 2 Impairs Macrophage Phagocytosis of Clostridium sordellii
dc.contributor.authorRogers, Lisa M.en_US
dc.contributor.authorThelen, Tennilleen_US
dc.contributor.authorFordyce, Krystleen_US
dc.contributor.authorBourdonnay, Emilieen_US
dc.contributor.authorLewis, Caseyen_US
dc.contributor.authorYu, Hanen_US
dc.contributor.authorZhang, Junyongen_US
dc.contributor.authorXie, Jinglien_US
dc.contributor.authorSerezani, Carlos H.en_US
dc.contributor.authorPeters‐golden, Marcen_US
dc.contributor.authorAronoff, David M.en_US
dc.date.accessioned2014-01-08T20:34:57Z
dc.date.available2015-03-02T14:35:35Zen_US
dc.date.issued2014-01en_US
dc.identifier.citationRogers, Lisa M.; Thelen, Tennille; Fordyce, Krystle; Bourdonnay, Emilie; Lewis, Casey; Yu, Han; Zhang, Junyong; Xie, Jingli; Serezani, Carlos H.; Peters‐golden, Marc ; Aronoff, David M. (2014). "EP4 and EP2 Receptor Activation of Protein Kinase A by Prostaglandin E 2 Impairs Macrophage Phagocytosis of Clostridium sordellii ." American Journal of Reproductive Immunology 71(1): 34-43.en_US
dc.identifier.issn1046-7408en_US
dc.identifier.issn1600-0897en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/102186
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherToxic Shock Syndromeen_US
dc.subject.otherPhagocytosisen_US
dc.subject.otherInnate Immunityen_US
dc.subject.otherEndometritisen_US
dc.subject.otherAbortionen_US
dc.subject.otherPregnancyen_US
dc.titleEP4 and EP2 Receptor Activation of Protein Kinase A by Prostaglandin E 2 Impairs Macrophage Phagocytosis of Clostridium sordelliien_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMicrobiology and Immunologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/102186/1/aji12153.pdf
dc.identifier.doi10.1111/aji.12153en_US
dc.identifier.sourceAmerican Journal of Reproductive Immunologyen_US
dc.identifier.citedreferenceGoulet V, Hebert M, Hedberg C, Laurent E, Vaillant V, De VH, Desenclos JC: Incidence of listeriosis and related mortality among groups at risk of acquiring listeriosis. Clin Infect Dis 2012; 54: 652 – 660.en_US
dc.identifier.citedreferenceSerezani CH, Ballinger MN, Aronoff DM, Peters‐Golden M: Cyclic AMP: master regulator of innate immune cell function. Am J Respir Cell Mol Biol 2008; 39: 127 – 132.en_US
dc.identifier.citedreferenceDi Benedetto G, Zoccarato A, Lissandron V, Terrin A, Li X, Houslay MD, Baillie GS, Zaccolo M: Protein kinase A type I and type II define distinct intracellular signaling compartments. Circ Res 2008; 103: 836 – 844.en_US
dc.identifier.citedreferenceKim SH, Serezani CH, Okunishi K, Zaslona Z, Aronoff DM, Peters‐Golden M: Distinct protein kinase A anchoring proteins direct prostaglandin E2 modulation of Toll‐like receptor signaling in alveolar macrophages. J Biol Chem 2011; 286: 8875 – 8883.en_US
dc.identifier.citedreferenceWHO: Maternal mortality in 2005: estimates developed by WHO, UNICEF, UNFPA and the World Bank ( http://www.who.int/whosis/mme_2005.pdf ) 2007.en_US
dc.identifier.citedreferenceAhman E, Shah IH: New estimates and trends regarding unsafe abortion mortality. Int J Gynaecol Obstet 2011; 115: 121 – 126.en_US
dc.identifier.citedreferenceFawcus SR: Maternal mortality and unsafe abortion. Best Pract Res Clin Obstet Gynaecol 2008; 22: 533 – 548.en_US
dc.identifier.citedreferenceSeale AC, Mwaniki M, Newton CR, Berkley JA: Maternal and early onset neonatal bacterial sepsis: burden and strategies for prevention in sub‐Saharan Africa. Lancet Infect Dis 2009; 9: 428 – 438.en_US
dc.identifier.citedreferenceMor G, Cardenas I: The immune system in pregnancy: a unique complexity. Am J Reprod Immunol 2010; 63: 425 – 433.en_US
dc.identifier.citedreferenceMason KL, Aronoff DM: Postpartum group A Streptococcus sepsis and maternal immunology. Am J Reprod Immunol 2012; 67: 91 – 100.en_US
dc.identifier.citedreferenceDeutscher M, Lewis M, Zell ER, Taylor TH Jr, Van Beneden C, Schrag S: Incidence and severity of invasive Streptococcus pneumoniae, group A Streptococcus, and group B Streptococcus infections among pregnant and postpartum women. Clin Infect Dis 2011; 53: 114 – 123.en_US
dc.identifier.citedreferenceSriskandan S: Severe peripartum sepsis. J R Coll Physicians Edinb 2011; 41: 339 – 346.en_US
dc.identifier.citedreferenceGarey KW, Jiang ZD, Yadav Y, Mullins B, Wong K, Dupont HL: Peripartum Clostridium difficile infection: case series and review of the literature. Am J Obstet Gynecol 2008; 199: 332 – 337.en_US
dc.identifier.citedreferenceRouphael NG, O'Donnell JA, Bhatnagar J, Lewis F, Polgreen PM, Beekmann S, Guarner J, Killgore GE, Coffman B, Campbell J, Zaki SR, McDonald LC: Clostridium difficile ‐associated diarrhea: an emerging threat to pregnant women. Am J Obstet Gynecol 2008; 198: 635 – e631.en_US
dc.identifier.citedreferenceHasegawa M, Kamada N, Jiao Y, Liu MZ, Nunez G, Inohara N: Protective role of commensals AGAINST Clostridium difficile infection via an IL‐1beta‐mediated positive‐feedback loop. J Immunol 2012; 189: 3085 – 3091.en_US
dc.identifier.citedreferenceJarchum I, Liu M, Shi C, Equinda M, Pamer EG: Critical Role for MyD88‐Mediated Neutrophil Recruitment during Clostridium difficile Colitis. Infect Immun 2012; 80: 2989 – 2996.en_US
dc.identifier.citedreferenceO'Brien DK, Melville SB: Effects of Clostridium perfringens alpha‐toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues. Infect Immun 2004; 72: 5204 – 5215.en_US
dc.identifier.citedreferenceO'Brien DK, Melville SB: Multiple effects on Clostridium perfringens binding, uptake and trafficking to lysosomes by inhibitors of macrophage phagocytosis receptors. Microbiology 2003; 149: 1377 – 1386.en_US
dc.identifier.citedreferenceVinals M, Bermudez I, Llaverias G, Alegret M, Sanchez RM, Vazquez‐Carrera M, Laguna JC: Aspirin increases CD36, SR‐BI, and ABCA1 expression in human THP‐1 macrophages. Cardiovasc Res 2005; 66: 141 – 149.en_US
dc.identifier.citedreferenceChuang PC, Lin YJ, Wu MH, Wing LY, Shoji Y, Tsai SJ: Inhibition of CD36‐dependent phagocytosis by prostaglandin E 2 contributes to the development of endometriosis. Am J Pathol 2010; 176: 850 – 860.en_US
dc.identifier.citedreferenceKvirkvelia N, Vojnovic I, Warner TD, Athie‐Morales V, Free P, Rayment N, Chain BM, Rademacher TW, Lund T, Roitt IM, Delves PJ: Placentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL‐2‐dependent proliferation of CTLL‐2 T cells. Clin Exp Immunol 2002; 127: 263 – 269.en_US
dc.identifier.citedreferenceParhar RS, Kennedy TG, Lala PK: Suppression of lymphocyte alloreactivity by early gestational human decidua I. Characterization of suppressor cells and suppressor molecules. Cell Immunol 1988; 116: 392 – 410.en_US
dc.identifier.citedreferenceScodras JM, Parhar RS, Kennedy TG, Lala PK: Prostaglandin‐mediated inactivation of natural killer cells in the murine decidua. Cell Immunol 1990; 127: 352 – 367.en_US
dc.identifier.citedreferenceTawfik OW, Hunt JS, Wood GW: Implication of prostaglandin E2 in soluble factor‐mediated immune suppression by murine decidual cells. Am J Reprod Immunol Microbiol 1986; 12: 111 – 117.en_US
dc.identifier.citedreferenceSlama H, Vaillancourt D, Goff AK: Pathophysiology of the puerperal period: relationship between prostaglandin E 2 (PGE 2 ) and uterine involution in the cow. Theriogenology 1991; 36: 1071 – 1090.en_US
dc.identifier.citedreferenceLiu W, Dubinett S, Patterson SL, Kelly KA: COX‐2 inhibition affects growth rate of Chlamydia muridarum within epithelial cells. Microbes Infect 2006; 8: 478 – 486.en_US
dc.identifier.citedreferenceTsuchiya S, Kobayashi Y, Goto Y, Okumura H, Nakae S, Konno T, Tada K: Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res 1982; 42: 1530 – 1536.en_US
dc.identifier.citedreferenceTsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K: Establishment and characterization of a human acute monocytic leukemia cell line (THP‐1). Int J Cancer 1980; 26: 171 – 176.en_US
dc.identifier.citedreferenceSoares EM, Mason KL, Rogers LM, Serezani CH, Faccioli LH, Aronoff DM: Leukotriene B 4 enhances innate immune defense against the puerperal sepsis agent Streptococcus pyogenes. J Immunol 2013; 190: 1614 – 1622.en_US
dc.identifier.citedreferenceAldape MJ, Bryant AE, Stevens DL: Clostridium sordellii infection: epidemiology, clinical findings, and current perspectives on diagnosis and treatment. Clin Infect Dis 2006; 43: 1436 – 1446.en_US
dc.identifier.citedreferenceZane S, Guarner J: Gynecologic clostridial toxic shock in women of reproductive age. Curr Infect Dis Rep 2011; 13: 561 – 570.en_US
dc.identifier.citedreferenceO'Brien DK, Therit BH, Woodman ME, Melville SB: The role of neutrophils and monocytic cells in controlling the initiation of Clostridium perfringens gas gangrene. FEMS Immunol Med Microbiol 2007; 50: 86 – 93.en_US
dc.identifier.citedreferenceParedes‐Sabja D, Cofre‐Araneda G, Brito‐Silva C, Pizarro‐Guajardo M, Sarker MR: Clostridium difficile spore‐macrophage interactions: spore survival. PLoS ONE 2012; 7: e43635.en_US
dc.identifier.citedreferenceParedes‐Sabja D, Sarker MR: Interactions between Clostridium perfringens spores and Raw 264.7 macrophages. Anaerobe 2012; 18: 148 – 156.en_US
dc.identifier.citedreferenceThelen T, Hao Y, Medeiros AI, Curtis JL, Serezani CH, Kobzik L, Harris LH, Aronoff DM: The class A scavenger receptor, macrophage receptor with collagenous structure, is the major phagocytic receptor for Clostridium sordellii expressed by human decidual macrophages. J Immunol 2010; 185: 4328 – 4335.en_US
dc.identifier.citedreferenceAronoff DM, Hao Y, Chung J, Coleman N, Lewis C, Peres CM, Serezani CH, Chen GH, Flamand N, Brock TG, Peters‐Golden M: Misoprostol impairs female reproductive tract innate immunity against Clostridium sordellii. J Immunol 2008; 180: 8220 – 8230.en_US
dc.identifier.citedreferenceHertelendy F, Zakar T: Prostaglandins and the myometrium and cervix. Prostaglandins Leukot Essent Fatty Acids 2004; 70: 207 – 222.en_US
dc.identifier.citedreferenceOlson DM, Ammann C: Role of the prostaglandins in labour and prostaglandin receptor inhibitors in the prevention of preterm labour. Front Biosci 2007; 12: 1329 – 1343.en_US
dc.identifier.citedreferenceKoeberle A, Werz O: Inhibitors of the microsomal prostaglandin E(2) synthase‐1 as alternative to non steroidal anti‐inflammatory drugs (NSAIDs)–a critical review. Curr Med Chem 2009; 16: 4274 – 4296.en_US
dc.identifier.citedreferenceFortier MA, Krishnaswamy K, Danyod G, Boucher‐Kovalik S, Chapdalaine P: A postgenomic integrated view of prostaglandins in reproduction: implications for other body systems. J Physiol Pharmacol 2008; 59 ( Suppl 1 ): 65 – 89.en_US
dc.identifier.citedreferenceSugimoto Y, Narumiya S: Prostaglandin E receptors. J Biol Chem 2007; 282: 11613 – 11617.en_US
dc.identifier.citedreferenceSreeramkumar V, Fresno M, Cuesta N: Prostaglandin E(2) and T cells: friends or foes? Immunol Cell Biol 2011; 90: 579 – 586.en_US
dc.identifier.citedreferenceKalinski P: Regulation of immune responses by prostaglandin E 2. J Immunol 2012; 188: 21 – 28.en_US
dc.identifier.citedreferenceAronoff DM, Canetti C, Peters‐Golden M: Prostaglandin E 2 inhibits alveolar macrophage phagocytosis through an E‐prostanoid 2 receptor‐mediated increase in intracellular cyclic AMP. J Immunol 2004; 173: 559 – 565.en_US
dc.identifier.citedreferenceBallinger MN, Aronoff DM, McMillan TR, Cooke KR, Olkiewicz K, Toews GB, Peters‐Golden M, Moore BB: Critical role of prostaglandin E 2 overproduction in impaired pulmonary host response following bone marrow transplantation. J Immunol 2006; 177: 5499 – 5508.en_US
dc.identifier.citedreferenceGoldmann O, Hertzen E, Hecht A, Schmidt H, Lehne S, Norrby‐Teglund A, Medina E: Inducible cyclooxygenase released prostaglandin E 2 modulates the severity of infection caused by Streptococcus pyogenes. J Immunol 2010; 185: 2372 – 2381.en_US
dc.identifier.citedreferenceSerezani CH, Kane S, Medeiros AI, Cornett AM, Kim SH, Marques MM, Lee SP, Lewis C, Bourdonnay E, Ballinger MN, White ES, Peters‐Golden M: PTEN directly activates the actin depolymerization factor cofilin‐1 during PGE 2 ‐mediated inhibition of phagocytosis of fungi. Sci Signal 2012; 5: ra12.en_US
dc.identifier.citedreferenceHertelendy F, Woods R, Jaffe BM: Prostaglandin E levels in peripheral blood during labor. Prostaglandins 1973; 3: 223 – 227.en_US
dc.identifier.citedreferenceKovatz S, Arber I, Korzets Z, Rathaus M, Ben Aderet N, Bernheim J: Urinary kallikrein in normal pregnancy, pregnancy with hypertension, and toxemia. Nephron 1985; 40: 48 – 51.en_US
dc.identifier.citedreferenceLee SE, Romero R, Park IS, Seong HS, Park CW, Yoon BH: Amniotic fluid prostaglandin concentrations increase before the onset of spontaneous labor at term. J Matern Fetal Neonatal Med 2008; 21: 89 – 94.en_US
dc.identifier.citedreferenceXie J, Cao S, Good D, Wei M, Ren X: Combination of a fluorescent dye and a Zn‐S cluster and its biological application as a stain for bacteria. Inorg Chem 2010; 49: 1319 – 1321.en_US
dc.identifier.citedreferenceWan CP, Park CS, Lau BH: A rapid and simple microfluorometric phagocytosis assay. J Immunol Methods 1993; 162: 1 – 7.en_US
dc.identifier.citedreferenceComerford KM, Lawrence DW, Synnestvedt K, Levi BP, Colgan SP: Role of vasodilator‐stimulated phosphoprotein in PKA‐induced changes in endothelial junctional permeability. FASEB J 2002; 16: 583 – 585.en_US
dc.identifier.citedreferenceBenz PM, Feller SM, Sickmann A, Walter U, Renne T: Prostaglandin‐induced VASP phosphorylation controls alpha II‐spectrin breakdown in apoptotic cells. Int Immunopharmacol 2008; 8: 319 – 324.en_US
dc.identifier.citedreferenceLivak KJ, Schmittgen TD: Analysis of relative gene expression data using real‐time quantitative PCR and the 2(‐Delta Delta C(T)) Method. Methods 2001; 25: 402 – 408.en_US
dc.identifier.citedreferenceAbramovitz M, Adam M, Boie Y, Carriere M, Denis D, Godbout C, Lamontagne S, Rochette C, Sawyer N, Tremblay NM, Belley M, Gallant M, Dufresne C, Gareau Y, Ruel R, Juteau H, Labelle M, Ouimet N, Metters KM: The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim Biophys Acta 2000; 1483: 285 – 293.en_US
dc.identifier.citedreferenceKatsuyama M, Ikegami R, Karahashi H, Amano F, Sugimoto Y, Ichikawa A: Characterization of the LPS‐stimulated expression of EP2 and EP4 prostaglandin E receptors in mouse macrophage‐like cell line, J774.1. Biochem Biophys Res Commun 1998; 251: 727 – 731.en_US
dc.identifier.citedreferenceIkegami R, Sugimoto Y, Segi E, Katsuyama M, Karahashi H, Amano F, Maruyama T, Yamane H, Tsuchiya S, Ichikawa A: The expression of prostaglandin E receptors EP2 and EP4 and their different regulation by lipopolysaccharide in C3H/HeN peritoneal macrophages. J Immunol 2001; 166: 4689 – 4696.en_US
dc.identifier.citedreferenceTakayama K, Garcia‐Cardena G, Sukhova GK, Comander J, Gimbrone MA Jr, Libby P: Prostaglandin E 2 suppresses chemokine production in human macrophages through the EP4 receptor. J Biol Chem 2002; 277: 44147 – 44154.en_US
dc.identifier.citedreferenceCheon H, Rho YH, Choi SJ, Lee YH, Song GG, Sohn J, Won NH, Ji JD: Prostaglandin E 2 augments IL‐10 signaling and function. J Immunol 2006; 177: 1092 – 1100.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
aji12153.pdf
Size:
324.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.